Pregled bibliografske jedinice broj: 708459
Difference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetic mellitus patients and healthy controls
Difference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetic mellitus patients and healthy controls // Annals of clinical biochemistry, 52 (2015), 2; 220-225 doi:10.1177/0004563214544709 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 708459 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Difference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetic mellitus patients and healthy controls
Autori
Zibar, Karin ; Knežević-Ćuća, Jadranka ; Blaslov, Kristina ; Bulum, Tomislav ; Smirčić-Duvnjak, Lea.
Izvornik
Annals of clinical biochemistry (0004-5632) 52
(2015), 2;
220-225
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
diabetes
Sažetak
The role of glucagon-like peptide-1 (GLP-1) has become a new scientific interest in the field of patho- physiology of type 1 diabetes mellitus (T1DM), but the results of the published studies were contradictory. The aim of our study was therefore to measure fasting and postprandial GLP-1 concentrations in T1DM patients and in healthy controls and to examine the difference in those concentrations between the two groups of subjects. The cross-sectional study included 30 C-peptide negative T1DM patients, median age 37 years (20–59), with disease duration 22 years (3–45), and 10 healthy controls, median age 30 years (27–47). Fasting and postprandial total and active GLP-1 concentrations were measured by ELISA (ALPCO, USA). The data were statistically analysed by SPSS, and significance level was accepted at P < 0.05. Both fasting total and active GLP-1 concentrations were significantly lower in T1DM patients (total 0.4pmol/L, 0–6.4 and active 0.2pmol/L, 0–1.9) compared with healthy controls (total 3.23pmol/L, 0.2–5.5 and active 0.8pmol/L, 0.2–3.6), P = 0.008 for total GLP-1 and P = 0.001 for active GLP-1. After adjustment for age, sex and body mass index, binary logistic regression showed that both fasting total and active GLP-1 remained significantly independently lower in T1DM patients (total GLP-1: OR 2.43, 95% CI 1.203– 4.909 and active GLP-1: OR 8.73, 95% CI 1.472– 51.787). T1DM patients had independently lower total and active GLP-1 fasting concentrations in comparison with healthy people, which supports the potential therapeutic role of incretin therapy, along with insulin therapy, in T1DM patients.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
045-1080230-0516 - Metabolički sindrom u šećernoj bolesti tipa 1 (Smirčić-Duvnjak, Lea, MZOS ) ( CroRIS)
Ustanove:
Klinička bolnica "Merkur",
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac,
Medicinski fakultet, Zagreb
Profili:
Lea Smirčić-Duvnjak
(autor)
Jadranka Knežević-Ćuća
(autor)
Karin Zibar Tomšić
(autor)
Tomislav Bulum
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE